Welcome to LookChem.com Sign In|Join Free
  • or
3-BROMO-5-(METHOXYCARBONYL)BENZENEBORONIC ACID 96, with the molecular formula C8H8BO4Br and a molecular weight of 249.95 g/mol, is a boronic acid derivative that serves as a versatile building block in organic synthesis. This white to off-white powder is widely used in the production of pharmaceuticals, agrochemicals, and materials science, playing a crucial role in the synthesis of biologically active compounds.

913835-87-7

Post Buying Request

913835-87-7 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

913835-87-7 Usage

Uses

Used in Pharmaceutical Industry:
3-BROMO-5-(METHOXYCARBONYL)BENZENEBORONIC ACID 96 is used as a key intermediate for the synthesis of various biologically active compounds, contributing to the development of new drugs with potential therapeutic applications.
Used in Agrochemical Industry:
In the agrochemical sector, 3-BROMO-5-(METHOXYCARBONYL)BENZENEBORONIC ACID 96 is utilized as a building block for the creation of novel agrochemicals, enhancing crop protection and yield.
Used in Materials Science:
3-BROMO-5-(METHOXYCARBONYL)BENZENEBORONIC ACID 96 is employed as a component in the synthesis of advanced materials, contributing to the development of innovative products with improved properties.
Used in Organic Synthesis:
As a boronic acid derivative, 3-BROMO-5-(METHOXYCARBONYL)BENZENEBORONIC ACID 96 is used in Suzuki-Miyaura cross-coupling reactions to form carbon-carbon bonds, facilitating the construction of complex organic molecules.
Used in Research and Laboratory Settings:
3-BROMO-5-(METHOXYCARBONYL)BENZENEBORONIC ACID 96 is commonly utilized in research and laboratory settings for the exploration of new synthetic routes and the development of novel compounds with potential applications in various industries.

Check Digit Verification of cas no

The CAS Registry Mumber 913835-87-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,1,3,8,3 and 5 respectively; the second part has 2 digits, 8 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 913835-87:
(8*9)+(7*1)+(6*3)+(5*8)+(4*3)+(3*5)+(2*8)+(1*7)=187
187 % 10 = 7
So 913835-87-7 is a valid CAS Registry Number.
InChI:InChI=1/C8H8BBrO4/c1-14-8(11)5-2-6(9(12)13)4-7(10)3-5/h2-4,12-13H,1H3

913835-87-7 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • Alfa Aesar

  • (H53223)  3-Bromo-5-(methoxycarbonyl)benzeneboronic acid, 96%   

  • 913835-87-7

  • 250mg

  • 1103.0CNY

  • Detail
  • Alfa Aesar

  • (H53223)  3-Bromo-5-(methoxycarbonyl)benzeneboronic acid, 96%   

  • 913835-87-7

  • 1g

  • 3528.0CNY

  • Detail

913835-87-7Downstream Products

913835-87-7Relevant academic research and scientific papers

Stereoselective Synthesis of New (2 S,3 R)-3-Carboxyphenyl)pyrrolidine-2-carboxylic Acid Analogues Utilizing a C(sp3)-H Activation Strategy and Structure-Activity Relationship Studies at the Ionotropic Glutamate Receptors

Bunch, Lennart,Hansen, Jacob C.,Hansen, Kasper B.,Iliadis, Stylianos,Kayser, Silke,Krogsgaard-Larsen, Niels,Larsen, Younes,Moroz, Aleksandra,Nielsen, Birgitte,Pickering, Darryl S.,Staudt, Markus,Syrenne, Jed T.,Temperini, Piero,Yi, Feng

, (2020)

Competitive antagonists for ionotropic glutamate receptors (iGluRs) are highly valuable tool compounds for studying health and disease states in the central nervous system. However, only few subtype selective tool compounds are available and the discovery of antagonists with novel iGluR subtype selectivity profiles remains a profound challenge. In this paper, we report an elaborate structure-activity relationship (SAR) study of the parental scaffold 2,3-trans-3-carboxy-3-phenyl-proline by the synthesis of 40 new analogues. Three synthetic strategies were employed with two new strategies of which one being a highly efficient and fully enantioselective strategy based on C(sp3)-H activation methodology. The SAR study led to the conclusion that selectivity for the NMDA receptors was a general trend when adding substituents in the 5′-position. Selective NMDA receptor antagonists were obtained with high potency (IC50 values as low as 200 nM) and 3-34-fold preference for GluN1/GluN2A over GluN1/GluN2B-D NMDA receptors.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 913835-87-7